Yahoo Finance • 5 days ago
ALVOTECH SA (NASDAQ:ALVO [https://www.chartmill.com/stock/quote/ALVO]) REPORTS STRONG Q2 2025 EARNINGS, BEATS REVENUE AND EPS ESTIMATES Alvotech SA, a global biotech company specializing in biosimilar medicines, reported its second-quarte... Full story
Yahoo Finance • 5 days ago
As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER... Full story
Yahoo Finance • 5 days ago
Yfir 200% aukning á tekjum af sölu lyfja á fyrri helmingi ársins miðað við sama tíma í fyrraAnnar ársfjórðungur sá besti í sögu félagsins hvað varðar handbært fé frá rekstri Nýir samningar um markaðsetningu endurspegla virði lyfja á fyrri... Full story
Yahoo Finance • 5 days ago
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story
Yahoo Finance • 12 days ago
REYKJAVIK, ICELAND (August 6, 2025) – Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results f... Full story
Yahoo Finance • 12 days ago
REYKJAVÍK (6. ágúst 2025) Alvotech (NASDAQ: ALVO) mun senda út tilkynningu með uppgjöri fyrir fyrri helming ársins 2025 eftir lokun markaða í Bandaríkjunum, miðvikudaginn 13. ágúst nk. Fundur til kynningar á uppgjörinu verður sendur út í b... Full story
Yahoo Finance • 12 days ago
REYKJAVIK, ISLAND (6 AUGUSTI, 2025) – Alvotech (NASDAQ:ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, publicerar bokslutskommun... Full story
Yahoo Finance • 21 days ago
* Alvotech (NASDAQ:ALVO [https://seekingalpha.com/symbol/ALVO]) filed automatic mixed securities shelf. * Filing [https://seekingalpha.com/filing/10225729] MORE ON ALVOTECH * Alvotech names veteran Linda Jónsdóttir finance chief [h... Full story
Yahoo Finance • 26 days ago
Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years.Dr. Reddy’s Laboratories Limited (NYSE:RDY) and Alvotech announced that they have entered into a collaboration and license agreement to co... Full story
Yahoo Finance • last month
REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as C... Full story
Yahoo Finance • last month
REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún hefur áður gegnt leiðtogastöðum fyrirtækja... Full story
Yahoo Finance • last month
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today annou... Full story
Yahoo Finance • last month
REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion o... Full story
Yahoo Finance • last month
Ivers-Lee er rótgróið fjölskyldufyrirtæki með höfuðstöðvar í Sviss og útibú í ÞýskalandiMeð kaupunum býr Alvotech sig undir mikinn vöxt eftirspurnar og eykur afköst í samsetningu og pökkun REYKJAVIK OG BURGDORF Í SVISS (9. JÚLÍ 2025) Alvo... Full story
Yahoo Finance • last month
REYKJAVIK, ISLAND UND BURGDORF, SCHWEIZ (9. JULI 2025) — Alvotech (NASDAQ: ALVO), ein globales Biotech-Unternehmen, das sich auf die Entwicklung und Herstellung von Biosimilars für Patienten weltweit spezialisiert hat, gab heute die Erweit... Full story
Yahoo Finance • 2 months ago
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco L... Full story
Yahoo Finance • 2 months ago
REYKJAVÍK og LONDON, BRETLANDI (1. júlí 2025) - Alvotech (NASDAQ: ALVO) og Advanz Pharma tilkynntu í dag að félögin hafi gert með sér samning um markaðssetningu AVT10 í Evrópu. AVT10 er hliðstæða við líftæknilyfið Cimzia (certolizumab pego... Full story
Yahoo Finance • 2 months ago
REYKJAVIK, ISLAND och LONDON, UK (1 juli 2025) — Alvotech (NASDAQ: ALVO), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära läkemedel för patienter över hela världen, och Advanz Pharma... Full story
Yahoo Finance • 2 months ago
Over the last 7 days, the United States market has risen 1.9% and is up 12% over the last 12 months, with earnings expected to grow by 14% per annum over the next few years. In this context of robust market performance, identifying high gr... Full story
Yahoo Finance • 2 months ago
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kas... Full story